The Epidemiological Features and Pathogen Spectrum of Respiratory Tract Infections, Istanbul, Türkiye, from 2021 to 2023.

The Epidemiological Features and Pathogen Spectrum of Respiratory Tract Infections, Istanbul, Türkiye, from 2021 to 2023.

Publication date: May 22, 2024

Respiratory tract infections (RTIs) can lead to both recurrent seasonal epidemic outbreaks and devastating pandemics. The aim of this study was to evaluate the epidemiologic characteristics and pathogen spectrum of RTIs using a multiplex RT-PCR panel. A total of 9354 cases with suspected RTIs between February 2021 and July 2023 were included in this study. A total of 11,048 nasopharyngeal and oropharyngeal samples from these patients were analyzed for 23 respiratory tract pathogens using multiplex RT-PCR. H. influenzae and S. pneumoniae were considered as colonizing bacteria. At least one pathogen was detected in 70. 66% of the samples; viral pathogens were detected in 48. 41% of the samples, bacterial pathogens were detected in 16. 06% of the samples, and viral + bacterial pathogens were detected in 35. 53% of the samples. The most frequently detected viral pathogen was rhinovirus/enterovirus (RV/EV) (19. 99%). Interestingly, in 2021, respiratory syncytial virus A/B showed atypical activity and replaced RV/EV as the most prevalent pathogen. Human bocavirus, H. influenzae, and S. pneumoniae were detected at higher rates in males (p: 0. 038, p: 0. 042, and p: 0. 035, respectively), while SARS-CoV-2 and B. pertussis were detected at higher rates in females (p < 0. 001 and p: 0. 033). RTIs were found at higher rates in children (p < 0. 001). SARS-CoV-2 and human coronaviruses 229E were detected at higher rates in adults (p < 0. 001 and p: 0. 001). This comprehensive study with a large sample size investigating RTI pathogens was the first in TcFCrkiye. Understanding the current viral circulation using multiplex RT-PCR panels enables clinicians to predict the most likely pathogens affecting patients and contributes to patient management, in addition to anticipating potential threats.

Open Access PDF

Concepts Keywords
Coronaviruses influenzae viruses
February multiplex RT-PCR
Istanbul RSV
July SARS-CoV-2
Pcr

Semantics

Type Source Name
disease IDO pathogen
disease MESH Respiratory Tract Infections
disease VO Optaflu
disease VO Bacteria
disease VO Enterovirus
disease VO Respiratory syncytial virus
disease MESH pertussis
pathway KEGG Pertussis
disease MESH Infectious Diseases
disease VO Viruses
disease MESH morbidity
disease VO organization
disease MESH death
disease MESH infections
disease MESH complications
disease MESH pneumonia
disease MESH myocarditis
disease MESH COVID 19
drug DRUGBANK Coenzyme M
disease VO time
disease MESH sore throat
disease VO protocol
disease VO manufacturer
disease VO USA
disease VO gene
disease MESH influenza
disease MESH parainfluenza
pathway KEGG Influenza A
drug DRUGBANK Estrone sulfate
drug DRUGBANK Esomeprazole
disease IDO assay
disease MESH common cold
disease MESH chronic obstructive pulmonary disease
disease MESH asthma
pathway KEGG Asthma
disease VO population
disease IDO infection
disease IDO immune response
disease MESH co infection
disease MESH Mycoplasma pneumonia
disease IDO host
drug DRUGBANK Spinosad
disease MESH Viral Infections
disease MESH Respiratory Syncytial Virus Infections
drug DRUGBANK Guanosine
disease MESH Bacterial Infections
disease MESH Clinical significance
disease MESH prostate cancer
pathway KEGG Prostate cancer
disease VO Canada

Original Article

(Visited 2 times, 1 visits today)